148 related articles for article (PubMed ID: 37949363)
1. Mortality, hospital length of stay, and recurrent bloodstream infections associated with extended-spectrum beta-lactamase-producing Escherichia coli in a low prevalence region: A 20-year population-based large cohort study.
Ling W; Paterson DL; Harris PNA; Furuya-Kanamori L; Edwards F; Laupland KB
Int J Infect Dis; 2024 Jan; 138():84-90. PubMed ID: 37949363
[TBL] [Abstract][Full Text] [Related]
2. Mortality and length of hospital stay after bloodstream infections caused by ESBL-producing compared to non-ESBL-producing
Handal N; Whitworth J; Lyngbakken MN; Berdal JE; Dalgard O; Bakken Jørgensen S
Infect Dis (Lond); 2024 Jan; 56(1):19-31. PubMed ID: 37795955
[TBL] [Abstract][Full Text] [Related]
3. Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort.
Leistner R; Gürntke S; Sakellariou C; Denkel LA; Bloch A; Gastmeier P; Schwab F
Infection; 2014 Dec; 42(6):991-7. PubMed ID: 25100555
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Extended-Spectrum-β-Lactamase-Producing
Baek YJ; Kim YA; Kim D; Shin JH; Uh Y; Shin KS; Shin JH; Jeong SH; Lee GW; Lee EJ; Kim DS; Park YS
Ann Lab Med; 2021 Sep; 41(5):455-462. PubMed ID: 33824233
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study.
Denis B; Lafaurie M; Donay JL; Fontaine JP; Oksenhendler E; Raffoux E; Hennequin C; Allez M; Socie G; Maziers N; Porcher R; Molina JM
Int J Infect Dis; 2015 Oct; 39():1-6. PubMed ID: 26189774
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing
Xiao T; Yang K; Zhou Y; Zhang S; Ji J; Ying C; Shen P; Xiao Y
Antimicrob Resist Infect Control; 2019; 8():144. PubMed ID: 31467670
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for antibiotic resistance and mortality in patients with bloodstream infection of Escherichia coli.
Zhao S; Wu Y; Dai Z; Chen Y; Zhou X; Zhao J
Eur J Clin Microbiol Infect Dis; 2022 May; 41(5):713-721. PubMed ID: 35190911
[TBL] [Abstract][Full Text] [Related]
9. A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections.
Xiao T; Wu Z; Shi Q; Zhang X; Zhou Y; Yu X; Xiao Y
J Glob Antimicrob Resist; 2019 Jun; 17():147-156. PubMed ID: 30634054
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal.
Ndir A; Diop A; Faye PM; Cissé MF; Ndoye B; Astagneau P
PLoS One; 2016; 11(2):e0143729. PubMed ID: 26867226
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.
Scheuerman O; Schechner V; Carmeli Y; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale PL; Oliver A; Ruiz-Garbajosa P; Gasch O; Gozalo M; Pitout J; Akova M; Peña C; Molina J; Hernández-Torres A; Venditti M; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Karaiskos I; de la Calle C; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Navarro-San Francisco C; Bonomo RA; Paterson DL; Pascual A; Rodríguez-Baño J;
Infect Control Hosp Epidemiol; 2018 Jun; 39(6):660-667. PubMed ID: 29618394
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for and mortality of extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections.
Superti SV; Augusti G; Zavascki AP
Rev Inst Med Trop Sao Paulo; 2009; 51(4):211-6. PubMed ID: 19739001
[TBL] [Abstract][Full Text] [Related]
13. A ten-year review of ESBL and non-ESBL Escherichia coli bloodstream infections among children at a tertiary referral hospital in South Africa.
Malande OO; Nuttall J; Pillay V; Bamford C; Eley B
PLoS One; 2019; 14(9):e0222675. PubMed ID: 31550295
[TBL] [Abstract][Full Text] [Related]
14.
MacKinnon MC; McEwen SA; Pearl DL; Parfitt EC; Pasquill K; Steele L; Laupland KB
Epidemiol Infect; 2021 Aug; 149():e195. PubMed ID: 34353396
[TBL] [Abstract][Full Text] [Related]
15. Costs and length of stay associated with extended-spectrum β-lactamase production in cases of Escherichia coli bloodstream infection.
Leistner R; Bloch A; Sakellariou C; Gastmeier P; Schwab F
J Glob Antimicrob Resist; 2014 Jun; 2(2):107-109. PubMed ID: 27873587
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
Ha YE; Kang CI; Cha MK; Park SY; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Int J Antimicrob Agents; 2013 Nov; 42(5):403-9. PubMed ID: 24071027
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
[TBL] [Abstract][Full Text] [Related]
18. Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.
Pascual V; Alonso N; Simó M; Ortiz G; Garcia MC; Xercavins M; Rivera A; Morera MA; Miró E; Espejo E; Navarro F; Gurguí M; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1997-2003. PubMed ID: 27549108
[TBL] [Abstract][Full Text] [Related]
19. Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy.
Tumbarello M; Sali M; Trecarichi EM; Leone F; Rossi M; Fiori B; De Pascale G; D'Inzeo T; Sanguinetti M; Fadda G; Cauda R; Spanu T
Antimicrob Agents Chemother; 2008 Sep; 52(9):3244-52. PubMed ID: 18591273
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing
Liang T; Xu C; Cheng Q; Tang Y; Zeng H; Li X
Microb Drug Resist; 2021 Jun; 27(6):800-808. PubMed ID: 33232654
[No Abstract] [Full Text] [Related]
[Next] [New Search]
